Walgreens Boots Alliance (WBA) announced September 20th that it is acquiring the remaining 30% stake in 340B specialty pharmacy company Shields Health Solutions that it did not already own. WBA first invested in Shields in July 2019. Last year, it spent about $970 million to raise its stake in Shields to about 70%. WBA announced that it is acquiring the remaining stake for approximately $1.37 billion. The transaction is expected to close by the end of the 2022 calendar year.
Shields is a leader in the large, fast-growing market of specialty pharmacy, and is one of the primary players to help 340B hospitals build out their own specialty pharmacy infrastructure. In January 2021, it purchased ExceleraRx, a specialty pharmacy network that consists of some of the most established specialty pharmacy programs in the country including Fairview Health, CommonSpirit, Avera Health, Intermountain, Banner and Monument Health.
Walgreens Boots Alliance (WBA) announced September 20
th that it is acquiring the remaining 30% stake in 340B specialty pharmacy company Shields Health Solutions that it did not already own.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
